Literature DB >> 3612401

Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia.

L A Page, J E Haddow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3612401     DOI： 10.1016/s0022-3476(87)80083-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

2.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

3.  Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.

Authors:  S H Pearce; D Trump; C Wooding; G M Besser; S L Chew; D B Grant; D A Heath; I A Hughes; C R Paterson; M P Whyte
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcaemia.

Authors:  H Wilkinson; J James
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

Review 5.  Familial benign hypercalcemia--from clinical description to molecular genetics.

Authors:  H Heath
Journal:  West J Med       Date:  1994-06

Review 6.  Uncoupling of secretion from growth in some hormone secretory tissues.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2014-07-08       Impact factor: 5.958

7.  Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.

Authors:  M R Pollak; Y H Chou; S J Marx; B Steinmann; D E Cole; M L Brandi; S E Papapoulos; F H Menko; G N Hendy; E M Brown
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia.

Authors:  Ksenia N Tonyushkina; Stephen O'Connor; Nancy S Dunbar
Journal:  Int J Pediatr Endocrinol       Date:  2012-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.